Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
Qiagen (NYSE:QGEN) was given a new $52.00 price target on by analysts at UBS Group AG.
Qiagen (NYSE:QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $60.00. They now have an "overweight" rating on the stock.
Qiagen (NYSE:QGEN) had its price target lowered by analysts at Citigroup Inc. from $55.40 to $55.00. They now have a "neutral" rating on the stock.
Qiagen (NYSE:QGEN) was given a new $53.00 price target on by analysts at Robert W. Baird.